Veteran biopharma executive Eric Matthews has joined Irving-based Caris Life Sciences, a leading next-generation AI TechBio company and precision medicine pioneer, as chief business officer, biopharma business development.
In that role, Matthews will provide strategic leadership to biopharma business development, and through his executive leadership, support Caris’ expanding portfolio of biopharma partnerships, Caris said.
“Eric’s proven track record in biopharma leadership and development strategy aligns perfectly with our corporate development efforts and strategic growth initiatives,” Caris President David Spetzler said in a statement.
Most recently, Matthews was the chief commercial officer at Arcus Biosciences. Before Arcus, he held the position of VP, franchise head, Immuno-Oncology Global Marketing at AstraZeneca. Matthews also held various leadership roles at Genentech, Roche, InterMune and GSK.
Caris said that throughout his career, Matthews has been involved with the Family Ranch Foundation, a nonprofit organization that financially supports families facing life-threatening diseases. Caris was founded with a vision to realize the potential of precision medicine in order to improve the human condition.
Caris also has offices in Phoenix, New York, Cambridge, Massachusetts, Tokyo, Japan and Basel, Switzerland.
Don’t miss what’s next. Subscribe to Dallas Innovates.
Track Dallas-Fort Worth’s business and innovation landscape with our curated news in your inbox Tuesday-Thursday.
R E A D N E X T
-
Fort Worth-based marketing agency The Starr Conspiracy has officially rebranded as TSC, signaling a new era with fresh leadership. CEO Ashley Bernard is steering the agency toward innovation, AI investment, and cutting-edge marketing strategies, with the rebrand unveiled at the 2024 HR Technology Conference & Exposition.
-
Trinity Christian Academy has named Lisa Wong, a former Raytheon engineer and TCA’s director of technology, as its first chief innovation officer. Wong will lead the integration of cutting-edge technology, foster innovation, and prepare students for future careers.
-
The 2024 iC3 Summit, hosted by nonprofit BioNTX, is set to welcome over 1,000 industry professionals, researchers, entrepreneurs, and investors for its largest gathering yet. The event's formula—Innovation = Capital × Collaboration × Commercialization,—underscores its mission to drive breakthroughs through strategic partnerships and investments. The 2024 iC3 Summit, hosted by nonprofit BioNTX, is set to welcome over 1,000 industry professionals, researchers, entrepreneurs, and investors for its largest gathering yet. The event's formula—Innovation = Capital × Collaboration × Commercialization—underscores its mission to drive breakthroughs through strategic partnerships and investments.
-
At Bisnow's Future of DFW Life Sciences Summit, Davis predicted a "snowball effect" of success in the next three to ten years as the life sciences industry grows. Davis has today's "Last Word."
-
Under the terms of the agreement, Caris is eligible to receive upfront and near-term payments of $25 million and is also eligible for up to $1.1 billion of potential research, development, commercial, and net sales payments, as well as potential tiered royalties on net sales of collaboration therapies, the company said.
